文献速递消化道肿瘤与早癌消化内镜

T1期结直肠癌切除后结肠与直肠肿瘤的生存和复发比较:长期队列研究

Comparison of survival and recurrence between colonic and rectal tumors after resection in T1 colorectal cancer: long-term cohort study.
PubMed 文献 · Gastrointest Endosc · 2025-06-11

本研究基于日本结直肠癌学会指南的病理淋巴结转移风险因素,将987例T1期结直肠癌切除患者分为低危组(A组)、仅内镜切除后高危组(B组)及外科切除或内镜联合外科切除后高危组(C组),比较结肠与直肠肿瘤的生存和复发。中位随访60个月,A、B组结肠与直肠肿瘤的疾病特异性生存率和累积复发率均无显著差异;C组中直肠病变量累积复发率显著更高(4.8% vs 1.1%,P=.002)且疾病特异性生存率显著更低(98.2% vs 99.8%,P=.024)。

要点

  • A组和B组中结肠与直肠肿瘤的疾病特异性生存率和累积复发率无显著差异。
  • C组直肠病变量累积复发率4.8% vs 结肠1.1%(P=.002),疾病特异性生存率98.2% vs 99.8%(P=.024)。
  • C组中直肠肿瘤位置(HR 3.25)、静脉侵犯(HR 9.40)和高出芽分级(HR 3.05)为独立复发风险因素。

核心结论

  • 高危病变行外科切除后,T1期直肠癌预后较T1期结肠癌差。
  • 高危T1期直肠癌伴静脉侵犯或高出芽分级需仔细监测。

研究设计与样本

  • 长期队列研究,共987例接受T1期结直肠癌切除的患者,中位随访60个月。
  • 按日本结直肠癌学会指南的病理淋巴结转移风险因素分为低危组(A组)、仅内镜切除后高危组(B组)和外科切除或内镜联合外科切除后高危组(C组)。

主要发现

  • A组结肠与直肠肿瘤的疾病特异性生存率99.2% vs 100%(P=.582),累积复发率2.3% vs 0%(P=.523),均无显著差异。
  • B组结肠与直肠肿瘤的疾病特异性生存率96.6% vs 100%(P=.577),累积复发率3.0% vs 0%(P=.399),均无显著差异。
  • C组直肠病变量累积复发率4.8% vs 结肠1.1%(P=.002),疾病特异性生存率98.2% vs 99.8%(P=.024)。
  • C组中直肠肿瘤位置(HR 3.25)、静脉侵犯(HR 9.40)和高出芽分级(HR 3.05)为独立复发风险因素。

关键数值与推荐

  • A组:结肠vs直肠疾病特异性生存率99.2% vs 100%(P=.582),累积复发率2.3% vs 0%(P=.523)。
  • B组:结肠vs直肠疾病特异性生存率96.6% vs 100%(P=.577),累积复发率3.0% vs 0%(P=.399)。
  • C组:直肠vs结肠累积复发率4.8% vs 1.1%(P=.002),疾病特异性生存率98.2% vs 99.8%(P=.024)。
  • C组独立复发风险因素:直肠肿瘤位置HR 3.25,静脉侵犯HR 9.40,高出芽分级HR 3.05。

临床怎么用

  • 高危T1期直肠癌伴静脉侵犯或高出芽分级需仔细监测(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Lesion location's impact on recurrence after T1 colorectal cancer (CRC) resection remains unclear. This study evaluated survival and recurrence differences between colonic and rectal tumors after T1 CRC resection. METHODS: Patients who underwent T1 CRC resection were reviewed on the basis of pathologic risk factors for lymph node metastases according to the Japanese Society for Cancer of the Colon and Rectum guidelines. Participants were divided into low-risk (group A), high-risk after endoscopic resection (ER) only (group B), and high-risk after surgical resection (SR) or ER and SR (group C) groups. Survival and recurrence rates were compared between colonic and rectal tumors. RESULTS: In 987 patients (median follow-up: 60 months), there were no significant differences in the disease-specific survival rate (A: 99.2% vs 100%, P = .582; B: 96.6% vs 100%, P = .577) or cumulative recurrence (A: 2.3% vs 0%, P = .523; B: 3.0% vs 0%, P = .399) between colonic and rectal tumors, respectively, in groups A and B. In group C, rectal lesions showed significantly higher cumulative recurrence (4.8% vs 1.1%, P = .002) and lower disease-specific survival rates (98.2% vs 99.8%, P = .024) than colonic lesions. Rectal tumor location (hazard ratio [HR], 3.25), venous invasion (HR, 9.40), and high budding grade (HR, 3.05) were independent recurrence risk factors in group C. CONCLUSIONS: T1 rectal cancer had a worse prognosis than T1 colonic cancer after high-risk lesion SR. Careful surveillance is required for high-risk T1 rectal cancers with venous invasion or a high budding grade.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Okumura T, Hotta K, Imai K, et al. Comparison of survival and recurrence between colonic and rectal tumors after resection in T1 colorectal cancer: long-term cohort study. Gastrointest Endosc. 2025. PMID: 40513800. doi:10.1016/j.gie.2025.06.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。